# Biotech Daily Digest â€” 2025-09-19

**33 items from 4 sources**

## Summary by Source

- Endpoints News: 10 items
- Fierce Biotech: 7 items
- Regeneron Press Releases: 1 item
- arXiv q-bio: 15 items


## Endpoints News

- **[The 2025 winners of the Endpoints 11: Biotech's most exciting startups](https://endpoints.news/the-2025-winners-of-the-endpoints-11-biotechs-most-exciting-startups/)**  
  _Fri, 19 Sep 2025 14:00:57 +0000_  
  Can superintelligent AI build a pipeline at the frontier of science? Can developers finally break down the barriers to treating solid tumors with in vivo CAR-T? Can the inherent promise of oncolytics be harnessed more ...

- **[Endpoints 11 winner 2025: Umoja Biopharma hopes to break CAR-T's in vivo barrier](https://endpoints.news/endpoints-11-winner-2025-umoja-biopharma-hopes-to-break-car-ts-in-vivo-barrier/)**  
  _Fri, 19 Sep 2025 14:00:42 +0000_  
  In vivo CAR-T is having a moment.

 In the space of six months, several ...

- **[Endpoints 11 winner 2025: Dispatch Bio's ambitious plans for solid tumor cell therapy](https://endpoints.news/endpoints-11-winner-2025-dispatch-bios-ambitious-plans-for-solid-tumor-cell-therapy/)**  
  _Fri, 19 Sep 2025 14:00:15 +0000_  
  When Carl June, Bob Nelsen and ...

- **[Endpoints 11 winner 2025: Stylus Medicine wants to bring CAR-T to the masses](https://endpoints.news/endpoints-11-winner-2025-stylus-medicine-wants-to-bring-car-t-to-the-masses/)**  
  _Fri, 19 Sep 2025 14:00:11 +0000_  
  Key leaders CEO Emile Nuwaysir, CSO Jason Fontenot; Scientific co-founders Ami Bhatt, Patrick Hsu, Michael Bassik and Lacramioara Bintu
 Total raised $85M 
 Headquarters Cambridge, MA
 Key investors RA Capital, Khosla ...

- **[Regeneron posts update on its muscle-sparing approach, a new quadruple agonist emerges at #EASD25](https://endpoints.news/regeneron-posts-update-on-its-muscle-sparing-approach-a-new-quadruple-agonist-emerges-at-easd25/)**  
  _Fri, 19 Sep 2025 11:20:28 +0000_  
  VIENNA â€” Eli Lilly was undoubtedly the star of this yearâ€™s congress of the European Association for the Study of Diabetes.

 Despite being slightly less effective than Novo Nordiskâ€™s rival pill, Lilly's oral ...

- **[Laura Shawver finds her next big bet; Sangamo CFO hands in resignation](https://endpoints.news/laura-shawver-finds-her-next-big-bet-sangamo-cfo-hands-in-resignation/)**  
  _Fri, 19 Sep 2025 11:00:34 +0000_  
  â†’ Laura Shawver likes AbbVie.

 The longtime industry stalwart is the new board chair at RNA medicines startup ADARx Pharmaceuticals. Shawver replaces

- **[FDA rescinds lab-developed test rule after court order](https://endpoints.news/fda-rescinds-lab-developed-test-rule-after-court-order/)**  
  _Thu, 18 Sep 2025 19:07:44 +0000_  
  The FDA is officially reversing a rule that brought laboratory-developed tests under the agencyâ€™s regulation.

 The move is a formality after a federal district court in Texas struck down the rule in ...

- **[Rare pediatric voucher reauthorization again advances out of House committee](https://endpoints.news/rare-pediatric-voucher-reauthorization-again-advances-out-of-house-committee/)**  
  _Thu, 18 Sep 2025 17:57:50 +0000_  
  For the second time in two years, the House Committee on Energy and Commerce advanced a bill that would restart the rare pediatric priority review voucher (PRV) program.

 The FDA program, created in 2012, awarded ...

- **[Nektarâ€™s stock rallies on eczema data; Novo to lay off 263 workers in NJ](https://endpoints.news/nektars-stock-rallies-on-eczema-data-novo-to-lay-off-263-workers-in-nj/)**  
  _Thu, 18 Sep 2025 14:47:51 +0000_  
  Plus, news about Bristol Myers Squibb, Nanobiotix, Biogen, bluebird bio, Kairos, BioCardia and Immuto Scientific:

 ðŸ§ª Nektar Therapeuticsâ€™ full Phase 2b eczema data: The company said rezpegaldesleukin, commonly known as rezpeg ...

- **[Pfizer, Arvinas to sell rights to lead PROTAC one month after filing for FDA review](https://endpoints.news/pfizer-arvinas-sell-rights-to-lead-protac-one-month-after-filing-for-fda-review/)**  
  _Thu, 18 Sep 2025 14:14:45 +0000_  
  Pfizer and Arvinas decided to out-license the lead program in their PROTAC collaboration after it fell short of expectations in late-stage clinical trials earlier this year.

 The companies said Wednesday that ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/two-years-after-carmot-buyout-whats-next-roches-expensive-obesity-pipeline" hreflang="en">Two years after Carmot buyout, whatâ€™s next for Rocheâ€™s expensive obesity pipeline?</a>](https://www.fiercebiotech.com/biotech/two-years-after-carmot-buyout-whats-next-roches-expensive-obesity-pipeline)**  
  _Sep 19, 2025 9:42am_  
  Itâ€™s been less than two years since Roche dove into the obesity space with its $2.7 billion acquisition of Carmot Therapeuticsâ€”but a lot has changed since then.

- **[<a href="https://www.fiercebiotech.com/biotech/chutes-ladders-catalym-catalyzes-c-suite-shakeup" hreflang="en">Chutes &amp; Laddersâ€”CatalYm catalyzes C-suite shakeup </a>](https://www.fiercebiotech.com/biotech/chutes-ladders-catalym-catalyzes-c-suite-shakeup)**  
  _Sep 18, 2025 5:13pm_  
  The German drug developer has tapped four industry leaders to take up spots in its C-suite, a move that has prompted three other executives to leave the company.

- **[<a href="https://www.fiercebiotech.com/pharma/kennedys-revamped-acip-contradicts-itself-confusion-tension-reign-over-mmrv-vaccine-vote" hreflang="en">RFK Jr.'s revamped ACIP contradicts itself as confusion, tension reign over MMRV vaccine vote</a>](https://www.fiercebiotech.com/pharma/kennedys-revamped-acip-contradicts-itself-confusion-tension-reign-over-mmrv-vaccine-vote)**  
  _Sep 18, 2025 6:36pm_  
  In a perplexing conclusion to an oftentimes tense meeting of the CDCâ€™s Advisory Committee on Immunization Practices Thursday, the panelistsâ€”assembled recently in the aftermath of Robert F. Kennedy Jr.â€™s purge of the committeeâ€”seemed to contradict themselves when it came time to vote on a vaccine recommendation.

- **[<a href="https://www.fiercebiotech.com/biotech/moderna-co-founder-robert-langers-son-launches-new-vc-775m-backing-dad" hreflang="en">Moderna co-founder Robert Langer's son launches new VC with $77.5M, backing from dad</a>](https://www.fiercebiotech.com/biotech/moderna-co-founder-robert-langers-son-launches-new-vc-775m-backing-dad)**  
  _Sep 18, 2025 2:47pm_  
  Renowned biotech veteran Robert Langer is the executive chair of T.Rx Capital, a VC co-founded by his son Michael Langer and aiming to back "visionary founders" at the intersection of technology and biology.

- **[<a href="https://www.fiercebiotech.com/medtech/stryker-siemens-healthineers-team-develop-stroke-treating-robot" hreflang="en">Stryker, Siemens Healthineers team up to develop stroke-treating robot</a>](https://www.fiercebiotech.com/medtech/stryker-siemens-healthineers-team-develop-stroke-treating-robot)**  
  _Sep 18, 2025 11:22am_  
  The two companies say the project will leverage Siemens Healthineersâ€™ expertise in imaging and robotics, plus Strykerâ€™s catalog of neurovascular hardware, and bring them together under a single platform.

- **[<a href="https://www.fiercebiotech.com/biotech/carismas-lifeline-dissipates-reverse-merger-plans-fall-through-moderna-cuts-ties" hreflang="en">Carismaâ€™s lifeline dissipates as reverse merger plans fall through, Moderna cuts ties</a>](https://www.fiercebiotech.com/biotech/carismas-lifeline-dissipates-reverse-merger-plans-fall-through-moderna-cuts-ties)**  
  _Sep 18, 2025 10:41am_  
  After Carisma Therapeutics laid off 95% of its team earlier this year, a Hail Mary merger proposal with another biotech has fallen through.

- **[<a href="https://www.fiercebiotech.com/biotech/arsenalbio-lays-50-staff-it-turns-away-early-stage-research" hreflang="en">UPDATED: ArsenalBio lays off 50% of staff in pivot from early-stage research</a>](https://www.fiercebiotech.com/biotech/arsenalbio-lays-50-staff-it-turns-away-early-stage-research)**  
  _Sep 17, 2025 4:57pm_  
  One of the top fundraisers of 2024 is halving its workforce about a year after bringing in a $325 million series C. Cell therapy biotech Arsenal Biosciences will lay off 50% of its staff as it restructures itself as a clinical-stage company, a spokesperson for the biotech has confirmed.


## Regeneron Press Releases

- **[Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks](https://investor.regeneron.com/news-releases/news-release-details/regeneron-donates-ebola-treatment-use-countries-most-risk)**  
  _Fri, 19 Sep 2025 07:00:00 -0400_  
  Inmazeb Â® Â  (atoltivimab, maftivimab, and odesivimab-ebgn) was the first treatment approved by theÂ U.S. Food and Drug Administration (FDA) for Orthoebolavirus zairense , also known as Zaire Â  ebolavirus Supply is being rushed to Democratic Republic of Congo (DRC) to help with the current outbreak


## arXiv q-bio

- **[Property-Isometric Variational Autoencoders for Sequence Modeling and Design](https://arxiv.org/abs/2509.14287)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2509.14287v1 Announce Type: new 
Abstract: Biological sequence design (DNA, RNA, or peptides) with desired functional properties has applications in discovering novel nanomaterials, biosensors, antimicrobial drugs, and beyond. One common challenge is the ability to optimize complex high-dimensional properties suâ€¦

- **[Theoretical Note: The Relation Between Structure and Dynamics in Psychological Networks of Attitudes](https://arxiv.org/abs/2509.14418)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2509.14418v1 Announce Type: new 
Abstract: Two claims of the Causal Attitude Network (CAN) model and the descendent Attitude Entropy framework (AE) are indicative of significant theoretical hurdles facing the psychological network modeling efforts of attitudes. The first claim is that the dynamics of change in aâ€¦

- **[Mouse vs. AI: A Neuroethological Benchmark for Visual Robustness and Neural Alignment](https://arxiv.org/abs/2509.14446)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2509.14446v1 Announce Type: new 
Abstract: Visual robustness under real-world conditions remains a critical bottleneck for modern reinforcement learning agents. In contrast, biological systems such as mice show remarkable resilience to environmental changes, maintaining stable performance even under degraded visâ€¦

- **[Charting trajectories of human thought using large language models](https://arxiv.org/abs/2509.14455)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2509.14455v1 Announce Type: new 
Abstract: Language provides the most revealing window into the ways humans structure conceptual knowledge within cognitive maps. Harnessing this information has been difficult, given the challenge of reliably mapping words to mental concepts. Artificial Intelligence large languagâ€¦

- **[Modelling species distributions using remote sensing predictors: Comparing Dynamic Habitat Index and LULC](https://arxiv.org/abs/2509.14862)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2509.14862v1 Announce Type: new 
Abstract: This study compares the predictive capacity of the Dynamic Habitat Index (DHI) - a remote sensing (RS)-based measure of habitat productivity and variability - against traditional land-use/land-cover (LULC) metrics in species distribution modelling (SDM) applications. RSâ€¦

- **[Network representations reveal structured uncertainty in music](https://arxiv.org/abs/2509.14053)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2509.14053v1 Announce Type: cross 
Abstract: Music, as a structured yet perceptually rich experience, can be modeled as a network to uncover how humans encode and process auditory information. While network-based representations of music are increasingly common, the impact of feature selection on structural propâ€¦

- **[A generative model of function growth explains hidden self-similarities across biological and social systems](https://arxiv.org/abs/2509.14468)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2509.14468v1 Announce Type: cross 
Abstract: From genomes and ecosystems to bureaucracies and cities, the growth of complex systems occurs by adding new types of functions and expanding existing ones. We present a simple generative model that generalizes the Yule-Simon process by including: (i) a size-dependentâ€¦

- **[Structure-Aware Contrastive Learning with Fine-Grained Binding Representations for Drug Discovery](https://arxiv.org/abs/2509.14788)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2509.14788v1 Announce Type: cross 
Abstract: Accurate identification of drug-target interactions (DTI) remains a central challenge in computational pharmacology, where sequence-based methods offer scalability. This work introduces a sequence-based drug-target interaction framework that integrates structural prioâ€¦

- **[Template-Based Cortical Surface Reconstruction with Minimal Energy Deformation](https://arxiv.org/abs/2509.14827)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2509.14827v1 Announce Type: cross 
Abstract: Cortical surface reconstruction (CSR) from magnetic resonance imaging (MRI) is fundamental to neuroimage analysis, enabling morphological studies of the cerebral cortex and functional brain mapping. Recent advances in learning-based CSR have dramatically accelerated pâ€¦

- **[Dynamic effects of electric field in hybrid coupling thermosensitive neuronal network](https://arxiv.org/abs/2509.14910)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2509.14910v1 Announce Type: cross 
Abstract: The dynamic of thermosensitive neuronal networks under the influence of external electric fields is explored, focusing on hybrid coupling models that incorporate both electrical and chemical synapses. Numerical simulations reveal a variety of complex behaviors, includâ€¦

- **[Individualized prescriptive inference in ischaemic stroke](https://arxiv.org/abs/2301.10748)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2301.10748v4 Announce Type: replace 
Abstract: The gold standard in the treatment of ischaemic stroke is set by evidence from randomized controlled trials, based on simple descriptions of presumptively homogeneous populations. Yet the manifest complexity of the brain's functional, connective, and vascular architâ€¦

- **[Synaptic Theory of Chunking in Working Memory](https://arxiv.org/abs/2408.07637)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2408.07637v2 Announce Type: replace 
Abstract: Working memory often appears to exceed its basic span by organizing items into compact representations called chunks. Chunking can be learned over time for familiar inputs; however, it can also arise spontaneously for novel stimuli. Such on-the-fly structuring is crâ€¦

- **[Life Finds A Way: Emergence of Cooperative Structures in Adaptive Threshold Networks](https://arxiv.org/abs/2507.13253)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2507.13253v2 Announce Type: replace 
Abstract: There has been a long debate on how new levels of organization have evolved. It might seem unlikely, as cooperation must prevail over competition. One well-studied example is the emergence of autocatalytic sets, which seem to be a prerequisite for the evolution of lâ€¦

- **[Controllable Surface Diffusion Generative Model for Neurodevelopmental Trajectories](https://arxiv.org/abs/2508.03706)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2508.03706v2 Announce Type: replace 
Abstract: Preterm birth disrupts the typical trajectory of cortical neurodevelopment, increasing the risk of cognitive and behavioral difficulties. However, outcomes vary widely, posing a significant challenge for early prediction. To address this, individualized simulation oâ€¦

- **[Radial Basis Function Techniques for Neural Field Models on Surfaces](https://arxiv.org/abs/2504.13379)**  
  _Fri, 19 Sep 2025 00:00:00 -0400_  
  arXiv:2504.13379v2 Announce Type: replace-cross 
Abstract: We present a numerical framework for solving neural field equations on surfaces using Radial Basis Function (RBF) interpolation and quadrature. Neural field models describe the evolution of macroscopic brain activity, but modeling studies often overlook the coâ€¦
